Abstracts Archive - Page 1496 of 2425 - ACR Meeting Abstracts

Abstract Number: 1175 • 2016 ACR/ARHP Annual Meeting
Thirty Day Readmission Rates for Patients Diagnosed with Systemic Lupus Erythematosus: Analysis at a Tertiary Care Center
Sadiq Ali¹, Stephen Mullis², Nkechi Emejuaiwe¹ and Dennis Ang¹, ¹Section on Rheumatology and Immunology, Wake Forest University, Winston Salem, NC, ²Department of Internal Medicine, Wake Forest University, Winston Salem, NC
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic illness that has been associated with high hospital readmission rates. Based on a recently published (Arth Rheumatol…
Abstract Number: 1176 • 2016 ACR/ARHP Annual Meeting
Prevalence of Influenza and Pneumococcal Polysaccharide Vaccine Administration and the Factors Affecting Vaccine Uptake in a Population of Patients with Autoimmune Inflammatory Rheumatic Diseases in a Brooklyn Clinic
De-Ann Williams¹, Rochelle Hardie¹, Asana Anderson¹ and Olga Dvorkina², ¹Internal Medicine, SUNY Health Science Center at Brooklyn, Brooklyn, NY, ²Medicine, SUNY Health Science Center at Brooklyn, Brooklyn, NY
Background/Purpose: Patients with autoimmune inflammatory rheumatic diseases (AIIRDs) are at increased risk for developing infections. The pathophysiology of the primary disease process, as well as…
Abstract Number: 1177 • 2016 ACR/ARHP Annual Meeting
Pneumocystis Jirovecii Pneumonia in Systemic Autoimmune Inflammatory Diseases
Shafay Raheel¹, Eric L. Matteson¹, Cynthia S. Crowson², Andrew Limper³, Eva M. Carmona Porquera³, Ulrich Specks⁴ and Misbah Baqir⁵, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Health Sciences Research, Mayo Clinic, Rochester, MN, ³Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, ⁴Mayo Clinic, Rochester, MN, ⁵Pulmonary/Critical Care, Mayo Clinic, Rochester, MN
Background/Purpose: Pneumocystis jirovecii pneumonia (PJP) is most frequently associated with AIDS, however, this infection also occurs in a variety of rheumatologic conditions in the context…
Abstract Number: 1178 • 2016 ACR/ARHP Annual Meeting
Is Subclinical Atherosclerosis Prevalent in a French Patient Cohort with Systemic Lupus Erythematosus?
Tess Van Meerhaeghe¹, Alexis Mathian¹, Matthieu Wargny¹, Miguel HIe¹, Micheline Pha¹, Julien Haroche², Fleur Cohen¹, Thi-Huang Du Boutin¹ and Zahir Amoura¹, ¹Department of Internal Medicine 2. Referal center for SLE/APS, Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France, ²Internal Medicine 2. Referal center for SLE/APS, Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France
Background/Purpose: Systemic lupus erythematosus (SLE) seems associated with an increased risk of cardiovascular disease. These data are mainly based on studies mostly from North America.…
Abstract Number: 1179 • 2016 ACR/ARHP Annual Meeting
The Impact of Autoimmune Disease in the Management and Prognosis of Acute Coronary Syndrome
Nuria Lozano-Rivas¹, Carlos Marras Fernandez-Cid², Francisco Jose Pastor Perez³, Pedro Flores-Blanco⁴, Miriam Gomez-Molina⁴, Alberto Bermudez⁵, Luis Francisco Linares², Javier Martinez Ferrin², Francisco Andrés Martinez-Angosto¹, Pablo Mesa del Castillo² and Sergio Manzano-Fernandez⁴, ¹Rheumatology, Hospital Virgen de la Arrixaca, murcia, Spain, ²Rheumatology, Hospital Virgen de la Arrixaca, Murcia, Spain, ³Cardiology, Hospital Virgen de la Arrixaca, Murcia, Spain, ⁴Cardiology, Hospital Virgen de la Arrixaca, murcia, Spain, ⁵Hospital Virgen de la Arrixaca, Molina de Segura (Mu, Spain
Background/Purpose: Patients with autoimmune diseases (AID) have a high burden of cardiovascular disease leading to premature morbidity and mortality. But it is unclear if it…
Abstract Number: 1180 • 2016 ACR/ARHP Annual Meeting
Class V Lupus Nephritis Results in Significant Numbers of End Stage Renal Disease and Death in a Population-Based Registry
Jennifer Brandt¹, Cristina Drenkard², Jason Cobb³, Gaobin Bao⁴ and S. Sam Lim⁴, ¹Department of Rheumatology, Emory University School of Medicine, Atlanta, GA, ²Emory University School of Medicine, Atlanta, GA, ³Department of Nephrology, Emory University School of Medicine, Atlanta, GA, ⁴Medicine, Emory University School of Medicine, Atlanta, GA
Background/Purpose: Although the diagnosis of pure class V lupus nephritis (LN) is generally thought to portend a favorable prognosis, outcomes on a population-level are not…
Abstract Number: 1181 • 2016 ACR/ARHP Annual Meeting
Risk Factors for Incident Fractures in Patients with Systemic Lupus Erythematosus on Dialysis
Brian Le^1,2, Jennifer Waller³, Reshmitha Radhakrishnan⁴, Sun Jung Oh⁴, Monique Bethel^2,5, Christopher Rice⁴ and Laura Carbone^2,6, ¹Department of Internal Medicine, Augusta University, Augusta, GA, ²Specialty Care, Charlie Norwood VA Medical Center, Augusta, GA, ³Biostatistics, Augusta University, Augusta, GA, ⁴School of Medicine, Augusta University, Augusta, GA, ⁵1120 15th Street, BI 5070, Augusta University, Augusta, GA, ⁶Rheumatology, Augusta University, Augusta, GA
Background/Purpose: Osteoporosis and osteoporotic fractures are significant comorbidities in patients with systemic lupus erythematosus (SLE). Hip fractures are being increasingly recognized as a complication of…
Abstract Number: 1182 • 2016 ACR/ARHP Annual Meeting
Opiod Use and Death in Chronic Pain Patients with Systemic Lupus Erythematosis
Romy Cabacungan¹, Clifford Qualls², Wilmer Sibbitt Jr.¹, Timothy Moore¹, Luis Salayandia¹, Roderick Fields³, Suzanne Emil¹, Monthida Fangtham¹, Konstantin Konstantinov⁴, Tej Bhavsar¹ and Arthur Bankhurst⁵, ¹Rheumatology, University of New Mexico, Albuquerque, NM, ²Biostatistics, UNM, Albuquerque, NM, ³Internal Medicine/ Rheumatology, University of New Mexico School of Medicine, Albuquerque, NM, ⁴1 University Of New Mexico, University of New Mexico, Albuquerque, NM, ⁵Rheumatology, University of NM Medical Center, Albuquerque, NM
Background/Purpose: Chronic pain is one of the most common symptoms reported in patients with SLE. Treating pain in these individuals can be complex and…
Abstract Number: 1183 • 2016 ACR/ARHP Annual Meeting
Lack of Awareness of Sexual Health in Rheumatology. High Prevalence of Sexual Dysfunction Among Women with Rheumatic Diseases
Alejandro Garza-Alpirez¹, David Vega-Morales², Wendy Orzua-de la Fuente¹, Ana Arana-Guajardo³, Diana Flores-Alvarado⁴, Jorge Esquivel-Valerio⁵, Mario Alberto Garza-Elizondo⁵ and Lorena Pérez-Barbosa⁶, ¹Servicio de Reumatología, Departamento de Medicina Interna. Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico, ²Universidad Autónoma de Nuevo Léon, Monterrey, Mexico, ³Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, ⁴Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico, ⁵Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, ⁶Hospital Universitario, Monterrey, Mexico
Background/Purpose: Rheumatic diseases comprise a diverse group of about 150 degenerative, autoimmune and autoinflammatory diseases. Sexual dysfunction affects about 70% of patients with rheumatic diseases…
Abstract Number: 1184 • 2016 ACR/ARHP Annual Meeting
Projected 2015 Prevalence of Physician-Diagnosed Primary SjöGren’s Syndrome Based on 1976-2005 Annual Incidence Rates in a Well-Defined U.S. Population
Divi Cornec¹, Eric L. Matteson² and Cynthia S. Crowson³, ¹Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, ²Rheumatology, Mayo Clinic, Rochester, MN, ³Health Sciences Research, Mayo Clinic, Rochester, MN
Background/Purpose: Estimates of prevalence of primary Sjögren’s syndrome (pSS) are conflicting, ranging from 1 to more than 8 cases per 10,000 according to different population-based…
Abstract Number: 1185 • 2016 ACR/ARHP Annual Meeting
Increased Risk of Osteoporotic Fractures in Patients with Primary SjöGren Syndrome: A Nationwide Population-Based Study in Taiwan
Yen Po Tsao^1,2, Yu Sheng Chang³, Chien Chih Lai^1,2, Wei Sheng Chen^1,2 and Chang Youh Tsai^4,5, ¹National Yang-Ming University, Taipei, Taiwan, ²Department of medicine, division of allergy, immunology, rheumatology, Taipei Veterans General Hospital, Taipei, Taiwan, ³Taipei Medical University, New Taipei City, Taiwan, ⁴Taipei Veterans General Hospital, Taipei, Taiwan, ⁵Department of medicine, division of allergy, immunology, rheumatology, National Yang-Ming University, Taipei, Taiwan
Background/Purpose: ö is an autoimmune disease involved multiple organs, including exocrine glands, lungs, and bone marrow. Patients with pSjS are vulnerable to fatigue and pain…
Abstract Number: 1186 • 2016 ACR/ARHP Annual Meeting
The Use of Clinical Mucosal Manifestations to Differentiate Patients with Lupus and Dermatomyositis: Transversal, Retrospective and Analytical Study of 116 Patients
Cristián Vera-Kellet Sr., Pablo del Barrio-Díaz Sr., Jorge Manríquez-Moreno Sr. and Carlos Reyes-Vivanco Sr., Dermatology, Pontificia Universidad Católica de Chile, Santiago, Chile
Background/Purpose: There are few studies comparing oral manifestations in patients with Cutaneous Lupus (CL), Systemic Lupus Erythematosus (SLE) and Dermatomyositis (DM). Our objective was to…
Abstract Number: 1187 • 2016 ACR/ARHP Annual Meeting
Ultraviolet Radiation Exposures Are Associated with Dermatomyositis in a National Myositis Registry
Christine G. Parks¹, Jesse Wilkerson², Kathryn M. Rose², Abdullah Faiq³, Payam Noroozi Farhadi³, Craig S. Long⁴, Nastaran Bayat³, Hermine I. Brunner⁵, Bob Goldberg⁶, John McGrath², Frederick W. Miller³ and Lisa G. Rider³, ¹Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Durham, NC, ²Social and Scientific Systems, Inc., Durham, NC, ³Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, NIH, Bethesda, MD, ⁴NOAA/National Weather Service, National Centers for Environmental Prediction Climate Prediction Center, College Park, MD, ⁵Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁶The Myositis Association, Alexandria, VA
Background/Purpose: Previous studies suggest exposure to ultraviolet (UV) radiation may be a risk factor for dermatomyositis (DM) and autoantibody phenotypes, based on differences in prevalence…
Abstract Number: 1188 • 2016 ACR/ARHP Annual Meeting
Major Comorbidities of Idiopathic Inflammatory Myositis: A Population-Based Study Using 10 Years of Follow up from the National Health Insurance in Korea
Jeong Seok Lee¹, Min Jung Kim², Hee Young Lee³, So Yeon Ahn⁴, Yeong Wook Song⁵, Eun Bong Lee⁶, Eun Young Lee⁷, Yun Jong Lee⁸ and Eun Ha Kang⁹, ¹Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, ²Division of Rheumatology, Departmenf of Internal Medicine, Seoul National University Hospital, Seoul, Korea, The Republic of, ³Center for Preventive Medicine and Public health, Seoul National University Bundang Hospital, Seongnam, Korea, The Republic of, ⁴Medical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam, Korea, The Republic of, ⁵Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Republic of Korea, Seoul, Korea, The Republic of, ⁶Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea, Seoul, Korea, The Republic of, ⁷Division of Rheumatology, Department of Internal Medicine, Seoul National University, Seoul, South Korea, ⁸Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea, ⁹Division of Rheumatology, Department of Internal Medicine, Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, The Republic of
Major comorbidities of idiopathic inflammatory myositis: A population-based study using 10 years of follow up from the national health insurance in KoreaJeong Seok Lee1, Min…
Abstract Number: 1189 • 2016 ACR/ARHP Annual Meeting
Inpatient Trends for Adults with Scleroderma in the United States: A 20 Year Analysis
Noopur Goel¹, Ishan Lalani² and Iram Moledina³, ¹Internal Medicine, Monmouth Medical Center, monmouth beach, NJ, ²Internal Medicine, Monmouth Medical Center, Ocean, NJ, ³Gujarat Adani Institute of Medical Sciences, New Haven, CT

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].